The next sacred mountain to protect the country! Why are Jinrenbao and Fubon betting on biotech and medical care
Posted: Wed Jan 08, 2025 4:28 am
Du Yijin, founder of Taiwan Artificial Intelligence Laboratory, said: "This cooperation with Microsoft Taiwan combines advanced and trustworthy AI, international cloud platforms, large-scale language generation models and other technologies. We can turn the next generation medical system into Taiwan's medical wisdom Join hands with Microsoft and enter the international market.”
Bian Zhixiang, general manager of Microsoft Taiwan, also pointed out: "Microsoft is committed to creating advanced artificial intelligence that can benefit everyone. In addition to continuing to invest in innovative AI technology around the world, as the preferred cloud platform and software services for the global industry, this time it has also joined hands with the Taiwan Artificial Intelligence Laboratory to Through the innovative application of artificial intelligence and medical care by both parties, we will respond to the government’s policy of promoting next-generation medical platforms and promote the digital transformation of Taiwan’s medical industry.”
Why did a big brother in the electronics industry and a leader in the financial industry choose to invest in the domestic biotechnology industry?
The National Biotechnology and Medical Industry Policy israel telegram Promotion Association (hereinafter referred to as the Biotechnology and Medical Industry Policy Association) held the "2023 Biotechnology and Medical Industry Policy Annual Meeting" on the 16th, inviting leaders from the government, biomedicine, technology, and finance to gather together. In terms of industry, the Biochemistry Association invited Xu Shengxiong, chairman of Jinrenbao, and Cai Mingxing, chairman of Fubon Financial Holdings, as speakers to analyze the development trends of the biomedical industry from the perspective of cross-industry investment.
For Jin Renbao, relying on its electronics industry can gain something in the field of smart medical care. For example, last year (2022) it announced an investment in Hongzhi Biomedical, which uses brain wave signals and AI to diagnose medical treatments. It has obtained approval from the US FDA and the Ministry of Health and Welfare. TFDA approval, and the construction of a large regional hospital in Ruifang, as an important field for the development of smart medicine, telemedicine, precision medicine and preventive medicine; Fubon Financial has been involved in the drug development industry chain, medical technology and equipment, precision medicine In medical and genetic testing, cell therapy, vaccines, health management, vaccines and many other fields, "medical insurance" is their target.
Bian Zhixiang, general manager of Microsoft Taiwan, also pointed out: "Microsoft is committed to creating advanced artificial intelligence that can benefit everyone. In addition to continuing to invest in innovative AI technology around the world, as the preferred cloud platform and software services for the global industry, this time it has also joined hands with the Taiwan Artificial Intelligence Laboratory to Through the innovative application of artificial intelligence and medical care by both parties, we will respond to the government’s policy of promoting next-generation medical platforms and promote the digital transformation of Taiwan’s medical industry.”
Why did a big brother in the electronics industry and a leader in the financial industry choose to invest in the domestic biotechnology industry?
The National Biotechnology and Medical Industry Policy israel telegram Promotion Association (hereinafter referred to as the Biotechnology and Medical Industry Policy Association) held the "2023 Biotechnology and Medical Industry Policy Annual Meeting" on the 16th, inviting leaders from the government, biomedicine, technology, and finance to gather together. In terms of industry, the Biochemistry Association invited Xu Shengxiong, chairman of Jinrenbao, and Cai Mingxing, chairman of Fubon Financial Holdings, as speakers to analyze the development trends of the biomedical industry from the perspective of cross-industry investment.
For Jin Renbao, relying on its electronics industry can gain something in the field of smart medical care. For example, last year (2022) it announced an investment in Hongzhi Biomedical, which uses brain wave signals and AI to diagnose medical treatments. It has obtained approval from the US FDA and the Ministry of Health and Welfare. TFDA approval, and the construction of a large regional hospital in Ruifang, as an important field for the development of smart medicine, telemedicine, precision medicine and preventive medicine; Fubon Financial has been involved in the drug development industry chain, medical technology and equipment, precision medicine In medical and genetic testing, cell therapy, vaccines, health management, vaccines and many other fields, "medical insurance" is their target.